Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by M101


PMN

RE:Still cheap

Looks like someone agrees with you this morning, soaked up supply from all...

April 28, 2023

PMN

RE:RE:back to breaking even:D

Probably some pundit's newsletter recommendation out there now that...

April 27, 2023

PMN

RE:RE:New Press Release - Data Presented at American Academy of Neurology Annual Meeting on Novel Vaccine Design for Alzheimer's Disease

Well, so much for getting top bullboard and some free attn. on Stockhouse...

April 26, 2023

PMN

RE:New Press Release - Data Presented at American Academy of Neurology Annual Meeting on Novel Vaccine Design for Alzheimer's Disease

let's get 100 likes!

April 25, 2023

PMN

RE:Brings back memories

That could be part of the reason for today's decent volume after the...

April 25, 2023

PMN

RE:More info from AD conference

Wow, the spin never stops at Alzforum, everything in that article presupposes...

April 24, 2023

PMN

RE:Competition is heating up

"The peptide used also is 12 amino acids long, which is longer than...

April 21, 2023

PMN

RE:Any thoughts?

FOMO

April 21, 2023

PMN

RE:Nice action today. IND approved?

Just someone using a large spread to move the price window upwards, sellers...

April 21, 2023

PMN

RE:RE:RE:Could PMN be a prime target for acquisition

Of course, got to demonstrate efficacy first. But the efficacy bar is just a...

April 20, 2023

PMN

RE:RE:Could PMN be a prime target for acquisition

Not that logic has anything to do with it but, we need cash, they have cash...

April 20, 2023

PMN

RE:Could PMN be a prime target for acquisition

This is why I don't expect Promis to remain independent through 2025, the...

April 19, 2023

PMN

RE:RE:RE:RE:New info an plaque removal

Thanks for that link. Of course it's not disinformation if it's...

April 18, 2023

PMN

RE:RE:New info an plaque removal

It's not just you Gbathat, there is an overton window at Alzforum...

April 18, 2023

PMN

RE:New info an plaque removal

They have a hammer, problem must be a nail.  "No matter the...

April 17, 2023

PMN

RE:RE:RE:RE:Nothing like a bit of fear to promote PMN310 science

Irrational exhuberance, the propellant for a moon shot is still efficacy. But...

April 16, 2023

PMN

RE:RE:RE:Nothing like a bit of fear to promote PMN310 science

You're probably right that it won't have any effect on the IND...

April 15, 2023

PMN

RE:RE:Nothing like a bit of fear to promote PMN310 science

5 MRIs each year to make sure each lecanemab patient is not one of the...

April 14, 2023

PMN

RE:RE:Nothing like a bit of fear to promote PMN310 science

Interesting how they first describe AD as "the woman’s hard-to-diagnose,...

April 14, 2023

PMN

RE:Nothing like a bit of fear to promote PMN310 science

wow, and they didn't see it coming so they haven't censored it yet

April 14, 2023

Featured Company